Open access peer-reviewed chapter

Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy

By Hitomi Fujie and Muneo Numasaki

Submitted: February 28th 2011Reviewed: September 1st 2011Published: February 3rd 2012

DOI: 10.5772/28436

Downloaded: 2468

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Hitomi Fujie and Muneo Numasaki (February 3rd 2012). Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy, Advancements in Tumor Immunotherapy and Cancer Vaccines Hilal Arnouk, IntechOpen, DOI: 10.5772/28436. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/advancements-in-tumor-immunotherapy-and-cancer-vaccines/type-iii-ifns-il-28-and-il-29-novel-interferon-family-members-with-therapeutic-potential-in-cancer-t" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2468total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Interleukin 12: Stumbling Blocks and Stepping Stones to Effective Anti-Tumor Therapy

By Hollie J. Pegram, Alena A. Chekmasova, Gavin H. Imperato and Renier J. Brentjens

Related Book

First chapter

The Dark Side of Cellular Plasticity: Stem Cells in Development and Cancer

By Fernando Abollo-Jimenez, Elena Campos-Sanchez, Ana Sagrera, Maria Eugenia Muñoz, Ana Isabel Galan, Rafael Jimenez and Cesar Cobaleda

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us